🤙🏻You know you're at the right place with the right people when having fun while working! Thanks @fibrotarget.bsky.social consortium for these two days full of science, foresight and anecdotes 😊 Very grateful for the conversations and the momentum ahead! 👣 #IBD #fibrosis #EUresearch #HorizonEurope

🎄 Bones festes i un 2026 ple de salut, èxits i molts projectes! 🎄 Quina sort haver pogut treballar aquest 2025 al costat de persones curioses, divertides, amables, humils i treballadores! 🔝🔝 Que puguem continuar contribuint plegats a la recerca i innovació sanitària durant el 2026! ✨💪🏻 #gratitude

🔬 Do you want to better understand what #RegulatoryImpact means & how to achieve it with your IMI or IHI project? 🚀 Join us on 10 Dec at 14:00 & find out! Hear from @ema.europa.eu regulators & past projects 👉 link.europa.eu/vGdQrY #IHITransformingHealth #HealthResearch #EUResearch #RegulatoryScience

L'acompanyament dels estudiants en l'etapa formativa és clau per veure que hi ha moltes més #sortideslaborals a més de marxar a l'estranger a fer un #postdoc Va ser un plaer explicar-vos el que fem a #Teamit i com el que heu fet fins ara és rellevant per a la nostra feina :) 🙌🏻 Molta sort! #Careers

📅 It’s official! #iDR26 lands in Brussels on 12–13 May 2026. Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding. Early Bird tickets available now ➡️ https://remedi4all.org/iDR26

🌄Teamit hosts the @remedi4all.bsky.social Hackathon! 14 ECRs joined a week of hands-on training in patient-centred drug repurposing, tackling real-world challenges in rare neurodevelopmental disorders. 🔗More about REMEDi4ALL: https://loom.ly/5eKcLZs

It was a pleasure to organise and attend the 4th #REMEDi4ALL General Assembly meeting in Ljubljana last week! Two full days of learnings, networking, and planning for the future of drug repurposing. Huge thanks to the consortium & UL team! Let’s keep making medicines accessible to patients 🌱 #Teamit

Today we’re sharing something a little different — a glimpse at the people behind #Teamit. 🌟 Five years in, we’re proud of how far we’ve come — and even more excited for what’s ahead. 💚 Watch the new video here: loom.ly/CCJuHh4 #MeetTheTeam #5YearsOfTeamit #Teamwork

🎉 What a conference! 🎉 Two energising days at #IDR25 in Amsterdam with Teamit as part of the organising & comms team for @remedi4all.bsky.social. Insightful talks, powerful patient stories & great connections. Thanks Beacon for Rare Diseases, #ZonMw! 👏 Until next time! #DrugRepurposing #EUHealth

#iDR25 by @remedi4all.bsky.social! 2.5 days full of patient stories, AI, policy discussions, trial designs & networking to make #DrugRepurposing the new normal💊🌍 👏Big thanks to all teams & speakers! 📰Great recap by @oriolguell.bsky.social EN: loom.ly/qzQoFDY #RareDiseases #PatientCentredResearch

Learn more about HTA & regulation in Drug Repurposing! Join the #iDR25 workshop series on 6 May in Amsterdam. Workshop 1️⃣: HTA—a key tool for patient access 🔧 Workshop 2️⃣: Navigating the regulatory path for repurposing 🗺️ Register here! ➡️ loom.ly/0sIBcrg

🎉 Proud moment! @remedi4all.bsky.social is featured in the @nytimes.com! 🗞️ The article highlights how #DrugRepurposing, powered by #AI, is addressing unmet medical needs👏 As partners, we’re thrilled to see these efforts gaining recognition! 🔗 Read here: loom.ly/1gYlyLM #RareDiseases #EuropeanHealth

Reducir la financiación de @gavi.org pondría en riesgo a millones de personas. Hay que garantizar un acceso equitativo a las vacunas. #ForOurFuture #HumanlyPossible #VaccinesWork

FIBROTARGET GAM#3 wrap-up! Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article! 📰Read our full wrap-up➡️ loom.ly/VDN6Fx4 📹Watch our highlights video below⬇️

What a pleasure to see all the progress we've been doing and discuss the challenges ahead: characterising the #fibrosis #biomarkers, defining #imaging diagnosis and prognosis, engaging with #patients and designing our #clinicaltrial! 🚀 Lots of learnings, discussions, networking and fun! #IBD #GAM3

FIBROTARGET GAM: Day 1 at Humanitas University in Milan Day 1 highlights: ✅ Patient insights from EFCCA ✅ New fibrosis biomarker research 🔬 ✅ Cutting-edge imaging 🏥 ✅ Laying the groundwork for a clinical trial 🏆 More soon—stay tuned! 🔍

📢 #iDR25: Venue announcement! We are excited to announce that #iDR25 will be held at Felix Meritis, an iconic Amsterdam venue! What to expect: 🔹 Engaging panels & talks 🔹 Networking opportunities 🔹 Interactive sessions Don’t miss out! Register➡️ loom.ly/xGqLsX4

Barcelona’s Green Corridors Plan shows how greening cities can reduce premature deaths, urban heat, and thermal stress. It could reduce mortality by 13 deaths per 100,000 people per year. 🟠 https://www.sciencedirect.com/science/article/pii/S0160412025000649?via%3Dihub #UrbanHealth #GreenSpaces

🎥Check out our new video on #DrugRepurposing! By building on what we know about a drug's safety & effectiveness, drug repurposing is accelerating the journey from lab to patient. Watch our video below to learn more, & visit 👉 remedi4all.org www.youtube.com/watch?v=w69O...

La intel·ligència artificial ofereix noves oportunitats per enriquir l'aprenentatge, però el seu ús ha de ser guiat per una aproximació crítica i responsable diarieducacio.cat/com-fer-serv...

👏🏻 Nice to continue seeing the impact from the EU-PEARL project 2 years later! @ihieurope.bsky.social #PPP #platformtrials #MDD #innovation

Introducing the #REMEDi4ALL Clinical Trials Webinar Series! 💻 Join Beacon for Rare Diseases, @eurordis.bsky.social & @ecrin.bsky.social for a 3-part series on clinical trials, starting Fri 21 Feb! 🔬 📅 Session 1: Intro to Clinical Trials + Q&A 🕚 11:00–12:30 CET 🎟️ Register now ➡️ loom.ly/I91LsfI

All the #NatureReviews journals and Nature Protocols are now on Bluesky, lots of Editors added to the starter pack too if you want to follow us 🧪 go.bsky.app/KcxvQLp

As climate change rapidly warms the Arctic, researchers raise concerns about the potential release of ancient microbes trapped in ice for millennia—posing threats to both human health and ecosystems. Learn more about this chilling risk & what can be done: tinyurl.com/2mhdhhje

Hallazgo bajo la Tierra: investigadores descubren un movimiento lento y silencioso que podría servir para predecir terremotos.

🌐💻 Calling all interested in Fibrosis in #IBD! Join EFCCA's webinar with leading experts from FIBROTARGET & patient reps. Dive into challenges, treatments, and innovations in #fibrosis!👥 🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET | 💻 Online 🎟️ Free: loom.ly/6WdjxOY

Barcelona se consolida como polo tecnológico y científico europeo www.lavanguardia.com/local/barcel...

#Tanzania faces another potential outbreak of #MarburgVirus. @who.int reports 9 suspected cases and 8 deaths in Kagera. Authorities have yet to confirm. 🔵 www.bbc.com/news/article... Via BBC | #Marburg #GlobalHealth

REMEDi4ALL is a #HorizonEU research initiative to drive forward the repurposing of medicines in Europe. The project, has the potential to reduce times & costs of drug development, making drug repurposing the new normal. 👉 More here: remedi4all.org #REMEDi4ALL #DrugRepurposing

🎉We're proud to announce that FIBROTARGET is now in action🎉 This €6M #HorizonEurope project aims to advance inflammatory bowel disease (#IBD) diagnosis and therapies🔬 You can learn more about the 5-year initiative below on our LIVE website🌐 fibrotarget.eu #fibrosis #fibrostenosis